Grzegorz S Nowakowski (Monica Mead, Grzegorz Nowakowski, Greg Nowakowski)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 37

Top Topics

Newly Diagnosed

Top Venues

Blood cancer journal

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Huong L Truong, Jason N Barreto, Kristin C Cole, Paul Joseph Hampel, Ivana N Micallef, Grzegorz S Nowakowski, Gita Thanarajasingam, Carrie A Thompson, Yucai Wang, Thomas E Witzig, Sandra M Herrmann, Nelson R Leung
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma. JCO oncology practice 20 (6) (2024)
Joseph C Lownik, Jonathan Boiarsky, Ruemu Ejedafeta Birhiray, Akil A Merchant, Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Joseph C Lownik, Jonathan Boiarsky, Ruemu Ejedafeta Birhiray, Akil A Merchant, Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Huong L Truong, Jason N Barreto, Kristin C Cole, Paul Joseph Hampel, Ivana N Micallef, Grzegorz S Nowakowski, Gita Thanarajasingam, Carrie A Thompson, Yucai Wang, Thomas E Witzig, Sandra M Herrmann, Nelson R Leung
Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma. JCO oncology practice (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Joseph C Lownik, Jonathan Boiarsky, Ruemu Ejedafeta Birhiray, Akil A Merchant, Grzegorz S Nowakowski
Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ramya Thota, Patricia A Hurley, Therica M Miller, Suanna Steeby Bruinooge, Craig Lipset, Robert Donald Harvey, Lora J Black, Amanda Dinsdale, Janette K Merrill, Teri Pollastro, Sheila A Prindiville, Mujahid A Rizvi, Shimere Sherwood, Grzegorz S Nowakowski
Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Joseph C Lownik, Jonathan Boiarsky, Ruemu Ejedafeta Birhiray, Akil A Merchant, Grzegorz S Nowakowski
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Grzegorz S Nowakowski, Dok Hyun Yoon, Patrizia Mondello, Erel Joffe, Anthea Peters, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Lorenzo Sabatelli, Eva E Waltl, Mark Winderlich, Andrea Sporchia, Nuwan C Kurukulasuriya, Raul Cordoba, Georg Hess, Gilles Salles
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma. Annals of hematology (2023)
Allison M Bock, Jennifer Jane Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew John Maurer, Brian F Kabat, Jonas Paludo, David J Inwards, Sabarish Ayyappan, Brian K Link, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, James R Cerhan, Umar Farooq, Yucai Wang
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Carmen E Guerra, Alice Pressman, Patricia A Hurley, Elizabeth Garrett-Mayer, Suanna Steeby Bruinooge, Alexandra Howson, Melinda Kaltenbaugh, Jen Hanley Williams, Leigh M Boehmer, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Lola Fashoyin-Aje, Worta McCaskill-Stevens, Janette K Merrill, Grzegorz S Nowakowski, Manali I Patel, Amelie G Ramirez, Victoria Zwicker, Randall A Oyer, Lori J Pierce
Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment. JCO oncology practice (2023)
Grzegorz S Nowakowski, Dok Hyun Yoon, Anthea C Peters, Patrizia Mondello, Erel Joffe, Isabelle Fleury, Richard Greil, Matthew Ku, Reinhard Marks, Kibum Kim, Pier Luigi Zinzani, Judith Trotman, Dan Huang, Eva E Waltl, Mark Winderlich, Nuwan C Kurukulasuriya, Sumeet Ambarkhane, Georg Hess, Gilles Andre Salles
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Sanjal H Desai, Levi D Pederson, Betsy LaPlant, Raphael Mwangi, Matthew John Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew L Feldman, David J Inwards, Ivana Micallef, Patrick Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood cancer journal 12 (5) (2022)
Yucai Wang, Shouhao Zhou, Xinyue Qi, Fang Yang, Matthew John Maurer, Thomas M Habermann, Thomas E Witzig, Michael L Wang, Grzegorz S Nowakowski
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials. Blood cancer journal 12 (1) (2022)
Darragh F O'Donoghue, Huong L Truong, Heidi D Finnes, Jennifer S McDonald, Heather Personett May, Stephen M Ansell, N Nora Bennani, Thomas M Habermann, David J Inwards, Patrick B Johnston, Arushi Khurana, Yi Lin, Ivana N Micallef, Grzegorz S Nowakowski, Jonas Paludo, Luis F Porrata, Gita Thanarajasingam, Carrie A Thompson, Jose C Villasboas Bisneto, Yucai Wang, Thomas E Witzig, Nelson R Leung
High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course. JCO oncology practice (2022)
Grzegorz S Nowakowski, Matthew John Maurer, James R Cerhan, Debarshi Dey, Laurie Helen Sehn
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma. American journal of hematology (2022)
Surbhi Sidana, Cristine Allmer, Melissa C Larson, Amylou C Dueck, Kathleen J Yost, Rahma M Warsame, Gita Thanarajasingam, James R Cerhan, Jonas Paludo, S Vincent Rajkumar, Thomas M Habermann, Grzegorz S Nowakowski, Yi Lin, Morie A Gertz, Thomas E Witzig, Angela Dispenzieri, Wilson I Gonsalves, Stephen M Ansell, Carrie A Thompson, Shaji K Kumar
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. JCO oncology practice 18 (8) (2022)
Randall A Oyer, Patricia A Hurley, Leigh M Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine J Barrett, Al Bowen Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Kyle DeLeon, Lola A Fashoyin-Aje, Elizabeth Garrett-Mayer, Julie R Gralow, Sybil Green, Carmen E Guerra, Leila Hamroun, Claudia M Hardy, Bridgette Hempstead, Sanford E Jeames, Mel Mann, Khalid Matin, Worta McCaskill-Stevens, Janette K Merrill, Grzegorz S Nowakowski, Manali I Patel, Alice R Pressman, Amelie G Ramirez, Juanita Segura, Barbara Segarra-Vasquez, Jen Hanley Williams, James E Williams, Karen M Winkfield, Eddy Shih-Hsin Yang, Victoria Zwicker, Lori J Pierce
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Patrizia Mondello, Angelo Fama, Melissa C Larson, Andrew L Feldman, Jose C Villasboas Bisneto, Zhi-Zhang Yang, Ilia Galkin, Viktor Svelolkin, Ekaterina Postovalova, Alexander Bagaev, Pavel Ovcharov, Arina Varlamova, Sarah Huet, Bruno Tesson, Kaitlyn R McGrath, Susan L Slager, Brian K Link, Sergei Syrbu, Anne J Novak, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, Gilles Andre Salles, James R Cerhan, Stephen M Ansell
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood cancer journal 11 (7) (2021)
Sanjal H Desai, Betsy LaPlant, William R Macon, Rebecca L King, Yucai Wang, David J Inwards, Ivana Micallef, Patrick B Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study. Blood cancer journal 11 (9) (2021)
Alessia Castellino, Aung Myint Tun, Yucai Wang, Thomas M Habermann, Rebecca L King, Kay M Ristow, James R Cerhan, David J Inwards, Jonas Paludo, Stephen M Ansell, Thomas E Witzig, Grzegorz S Nowakowski
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma. Blood cancer journal 11 (1) (2021)
Bruce D Cheson, Grzegorz S Nowakowski, Gilles Salles
Diffuse large B-cell lymphoma: new targets and novel therapies. Blood cancer journal 11 (4) (2021)
null Arushi Khurana, Raphael Mwangi, Stephen M Ansell, Thomas M Habermann, James R Cerhan, Christopher Strouse, Brian K Link, Yucai Wang, Rebecca L King, William R Macon, Jose C Villasboas Bisneto, Thomas E Witzig, Matthew John Maurer, Grzegorz S Nowakowski
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood cancer journal 11 (7) (2021)
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, David W Scott, Qingyuan Zhang, Wojciech Jurczak, Muhit Özcan, Xiaonan Hong, Jun Zhu, Jie Jin, David Belada, Juan-Miguel Bergua, Francesco A Piazza, Heidi Mócikova, Anna Lia Molinari, Dok Hyun Yoon, Federica Cavallo, Monica Tani, Kazuhito Yamamoto, Koji Izutsu, Koji Kato, Myron Czuczman, Sarah Hersey, Adrian Kilcoyne, Jacqueline Russo, Krista Hudak, Jingshan Zhang, Steve Wade, Thomas E Witzig, Umberto Vitolo
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Grzegorz S Nowakowski, Fangxin Hong, David W Scott, William R Macon, Rebecca L King, Thomas M Habermann, Nina Wagner-Johnston, Carla Casulo, James L Wade, Gauri G Nagargoje, C M Reynolds, Jonathon B Cohen, Nadia Khan, Jennifer Effie Amengual, Kristy L Richards, Richard F Little, John P Leonard, Jonathan W Friedberg, Lale Kostakoglu, Brad S Kahl, Thomas E Witzig
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, Thomas M Habermann, Stephen M Ansell, Betsy R LaPlant, Brian L Link, James R Cerhan, Matthew John Maurer, Thomas E Witzig
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Grzegorz S Nowakowski
Evolution: IMiDs to PPMs, revolution in DLBCL? Blood 126 (6) (2015)